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Relationship between obstructive coronary artery disease
and abnormal stress testing in patients with paroxysmal or
persistent atrial fibrillation
Abstract
Atrial fibrillation (AF) has been linked to the presence of underlying coronary artery disease
(CAD). However, whether the higher burden of CAD observed in AF patients translates into
higher burden of myocardial ischemia is unknown. In 87 patients (71% male, mean age
61 ± 10 years) with paroxysmal or persistent AF and without history of CAD, MSCT
coronary angiography and stress testing (exercise ECG test or myocardial perfusion imaging)
were performed. CAD was classified as obstructive (≥50% luminal narrowing) or not. Stress
tests were classified as normal or abnormal. A population of 122 patients without history of
AF, similar to the AF group as to age, gender, symptomatic status and pre-test likelihood,
served as a control group. Based on MSCT, 17% of AF patients were classified as having no
CAD, whereas 43% showed non-obstructive CAD and the remaining 40% had obstructive
CAD. A positive stress test was observed in 49% of AF patients with obstructive CAD. Among
non-AF patients, 34% were classified as having no CAD, while 41% showed non-obstructive
CAD and 25% had obstructive CAD (P = 0.013 compared to AF patients). A positive stress
test was observed in 48% of non-AF patients with obstructive CAD. In conclusion, the higher
burden of CAD observed in AF patients is not associated to higher burden of myocardial
ischemia.
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Abstract Atrial fibrillation (AF) has been linked to
the presence of underlying coronary artery disease
(CAD). However, whether the higher burden of CAD
observed in AF patients translates into higher burden
of myocardial ischemia is unknown. In 87 patients
(71% male, mean age 61 ± 10 years) with paroxys-
mal or persistent AF and without history of CAD,
MSCT coronary angiography and stress testing
(exercise ECG test or myocardial perfusion imaging)
were performed. CAD was classified as obstructive
(C50% luminal narrowing) or not. Stress tests were
classified as normal or abnormal. A population of 122
patients without history of AF, similar to the AF group
as to age, gender, symptomatic status and pre-test
likelihood, served as a control group. Based on MSCT,
17% of AF patients were classified as having no CAD,
whereas 43% showed non-obstructive CAD and the
remaining 40% had obstructive CAD. A positive stress
test was observed in 49% of AF patients with
obstructive CAD. Among non-AF patients, 34% were
classified as having no CAD, while 41% showed non-
obstructive CAD and 25% had obstructive CAD
(P = 0.013 compared to AF patients). A positive
stress test was observed in 48% of non-AF patients
with obstructive CAD. In conclusion, the higher
burden of CAD observed in AF patients is not
associated to higher burden of myocardial ischemia.
Keywords Atrial fibrillation  Coronary artery
disease  Multi-slice computed tomography 
Prevalence  Risk stratification  Stress testing
Introduction
Atrial fibrillation (AF) has been shown to be an
independent risk factor for future coronary artery
disease (CAD) events [1–6]. Accordingly, evaluation
of AF patients for CAD may potentially be useful, in
order to improve their outcome.
Multi-slice computed tomography (MSCT) coronary
angiography has emerged as an accurate technique
G. Nucifora  J. D. Schuijf  J. M. van Werkhoven 
S. A. Trines  L. F. Tops  J. W. Jukema 
E. E. van der Wall  M. J. Schalij  J. J. Bax (&)
Department of Cardiology, Leiden University Medical
Center, Albinusdreef 2, P.O. Box 9600,
2300 RC Leiden, The Netherlands
e-mail: J.J.Bax@lumc.nl
S. Kajander  O. Turta  J. Knuuti
Turku PET Center, Turku University Central Hospital,
Turku, Finland
J. W. Jukema
The Interuniversity Cardiology Institute of the
Netherlands, Utrecht, the Netherlands
J. H. M. Schreur  M. W. Heijenbrok
Departments of Cardiology and Radiology, Medisch
Centrum Haaglanden, Leidschendam, The Netherlands
O. Gaemperli  P. A. Kaufmann
Cardiovascular Center, University Hospital Zurich,
Zurich, Switzerland
123
Int J Cardiovasc Imaging (2011) 27:777–785
DOI 10.1007/s10554-010-9725-x
for the non-invasive imaging of coronary atheroscle-
rosis [7]. In a recent study using MSCT coronary
angiography, a higher prevalence of CAD and obstruc-
tive CAD was found among patients with paroxysmal
or persistent AF, as compared to patients without a
history of AF; in addition, a significant independent
relation between AF and CAD was observed [8].
However, MSCT coronary angiography does not
provide information about the hemodynamic conse-
quences of observed coronary lesions [9, 10]; there-
fore, whether the higher burden of CAD observed in
AF patients is associated also to a higher burden of
myocardial ischemia remains to be determined.
Accordingly, the aim of the present study was to
evaluate the relation between the evidence of coronary
atherosclerosis (by means of MSCT coronary angiog-
raphy) and the presence of abnormal stress testing
among patients with paroxysmal or persistent AF and
compare findings to patients without a history of AF.
Methods
Patient population
A total of 87 patients from the outpatient clinic with a
history of paroxysmal (n = 54, 62%) or persistent
(n = 33, 38%) AF, referred to MSCT for coronary
evaluation, due to an elevated risk profile and/or chest
pain, were included. In addition, patients underwent
stress testing (exercise ECG testing [EET] or myo-
cardial perfusion imaging [MPI]) within 1 month of
MSCT coronary angiography.
The patient population is part of an ongoing study
protocol addressing the value of MSCT and other
imaging techniques in patients with paroxysmal or
persistent AF. From this prospective registry, results
addressing the prevalence of CAD by MSCT coro-
nary angiography in AF patients have been recently
published [8].
Patients with history of CAD and contraindications
to MSCT were excluded. Only patients in sinus
rhythm were included, and patients with AF at the
time of SPECT or MPI were excluded. Paroxysmal
and persistent AF were diagnosed according to the
American Heart Association/American College of
Cardiology/European Society of Cardiology criteria
[11]. A history of CAD was defined as the presence
of previous acute coronary syndrome, percutaneous
or surgical coronary revascularization, and/or one or
more angiographically documented coronary stenosis
C50% luminal diameter [9]. Contraindications for
MSCT were (1) known allergy to iodinated contrast
agent, (2) renal failure, (3) pregnancy.
For each patient, the presence of coronary risk
factors (diabetes, systemic hypertension, hypercholes-
terolemia, positive family history of CAD and cigarette
smoking) and symptoms was recorded. In addition, the
pre-test likelihood of obstructive CAD was evaluated
using the Diamond and Forrester criteria [12, 13].
A control group was selected from the clinical
database for comparison purposes. Accordingly, 122
patients were included without history of AF and with
similar baseline clinical characteristics; these patients
were clinically referred to MSCT for coronary
evaluation and stress testing within 1 month.
Patients were included at 4 centers in 3 different
countries (Leiden University Medical Center, Leiden,
the Netherlands; Medisch Centrum Haaglanden, Le-
idschendam, The Netherlands; Turku PET Center,
Turku, Finland; University Hospital Zurich, Zurich,
Switzerland).
MSCT data acquisition
The heart rate and blood pressure were monitored
before the examination in each patient. In the absence
of contraindications, patients with a heart rate C65
beats/min were administered beta-blocking medica-
tion (50–100 mg metoprolol, oral or 5–10 mg meto-
prolol, intravenous).
MSCT coronary angiography was performed with
either 16-slice MSCT scanner (n = 39; Aquilion 16,
Toshiba Medical Systems, Japan and Discovery STE,
General Electrics, USA) or 64-slice MSCT scanner
(n = 170; Aquilion 64, Toshiba Medical Systems,
Japan, LightSpeed VCT, GE Healthcare, USA and
Discovery VCT, General Electrics, USA). The esti-
mated radiation dose was between 10 and 18 mSv.
Data were subsequently transferred to dedicated
workstations for post-processing and evaluation
(Advantage, GE Healthcare, USA; Vitrea 2, Vital
Images, USA; and Aquarius, TeraRecon, USA).
MSCT data analysis
The MSCT data analysis was performed in each
center by two experienced observers who had no
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knowledge of the patient’s medical history, symptom
status and stress testing results; disagreement was
solved by consensus or evaluation by a third
observer. Standardized MSCT data evaluation meth-
odology and scoring system described below were
used in each center.
MSCT coronary angiograms obtained with 16 and
64-slice scanners were evaluated for the presence of
obstructive CAD (C50% luminal narrowing) on a
patient and vessel level. For this purpose, both the
original axial dataset as well as curved multiplanar
reconstructions were used. Each vessel was evaluated
for the presence of any atherosclerotic plaque,
defined as structures [1 mm2 within and/or adjacent
to the coronary artery lumen, which could be clearly
distinguished from the vessel lumen and the sur-
rounding pericardial tissue, as described previously
[14]. Subsequently, the vessels were further classified
as (1) completely normal, (2) having non-obstructive
CAD when atherosclerotic lesions \50% of luminal
diameter were present or (3) having obstructive CAD
when atherosclerotic lesions C50% of luminal diam-
eter were present.
The presence of CAD (including obstructive and
non-obstructive CAD), and obstructive CAD were
evaluated. In addition, the presence of (1) single-
vessel disease (obstructive CAD in one vessel);
(2) multi-vessel disease (obstructive CAD in more
than one vessel) and (3) obstructive CAD in the left
main (LM) and/or proximal left anterior descending
(LAD) coronary artery was evaluated. Multi-vessel
disease and LM and/or proximal LAD disease were
considered to represent high-risk features.
Stress testing
Stress testing was performed in all patients within
1 month of MSCT coronary angiography after an
adequate pharmacological wash-out; beta-blockers,
long-acting nitrates and calcium channel blockers
were discontinued at least 48 h before the test.
Exercise ECG test
Symptom-limited EET was performed on a bicycle
ergometer according to standard protocols [15].
Patients not able to reach C85% age-predicted
maximum heart rate in the absence of ischemic
changes were not included in the study.
The test was analyzed by an experienced reader
who had no knowledge of the MSCT results and was
classified as positive or negative for ischemia. The
test was considered positive based on the presence of
C0.1 mV horizontal or downsloping ST-segment
depression at 80 ms after the J point in two contig-
uous leads during exercise or recovery.
Myocardial perfusion imaging
Stress-rest MPI was performed with symptom-limited
bicycle exercise or pharmacologic (adenosine or
dobutamine) stress using either technetium-99 m
tetrofosmin or technetium-99 m sestamibi. Images
were acquired with either a dual-head (Millenium VG
& Hawkeye; GE Healthcare, Waukesha, Wisconsin) or
a triple-head (GCA 9300/HG, Toshiba Corp., Japan)
single-photon emission computed tomographic
(SPECT) camera, and reconstructed into long- and
short-axis projections perpendicular to the heart axis.
The estimated radiation dose for stress-rest MPI was
approximately 7 mSv.
The test was analyzed by an experienced reader
who had no knowledge of the MSCT results.
Perfusion defects were identified on the stress images
(segmental tracer activity \75% of maximum) and
divided into ischemia (reversible defects, with C10%
increase in tracer uptake on the resting images) or
scar tissue (irreversible defects). Accordingly, exam-
inations were classified as being either negative or
positive. Positive examinations were further divided
into those demonstrating reversible defects and those
demonstrating fixed defects. The gated images were
used to assess regional wall motion to improve
differentiation between perfusion abnormalities and
attenuation artifacts [16].
Statistical analysis
Continuous variables are expressed as mean and
standard deviation. Categorical variables are expressed
as absolute numbers and percentages.
The differences in continuous variables were
assessed using the Student t test. Chi-square or Fisher
exact test, when appropriate, were computed to test
for differences in categorical variables.
A P value \ 0.05 was considered statistically sig-
nificant. Statistical analyses were performed using SPSS
software (version 15.0, SPSS Inc, Chicago, Il, USA).
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Results
Patient characteristics
Baseline characteristics of each group are shown in
Table 1. By definition, AF and non-AF groups did
not differ as to mean age (61 ± 10 vs. 59 ±
11 years), male gender (71% vs. 66%), symptomatic
status and pre-test likelihood of CAD. In addition, no
difference in coronary risk factor profile was
observed between the two groups.
MSCT coronary angiography
Table 2 shows the results of MSCT coronary angi-
ography among AF and non-AF patients. Overall, a
significantly higher prevalence of obstructive CAD
was observed among AF patients, as compared to
non-AF patients (P = 0.013; Table 2). Single-vessel
disease and LM and/or proximal LAD disease were
more frequently observed in AF patients (P = 0.027
and P = 0.003, respectively; Table 2).
Stress testing
Table 3 shows the stress testing results among AF
and non-AF patients.
Symptom-limited EET was performed in 38 (44%)
AF patients and in 48 (39%) non-AF patients. Ischemic
ST-segment depression was observed in 15 (39%) AF
patients and in 14 (29%) non-AF patients (P = 0.32;
Table 3). When considering only the symptomatic
patients, symptom-limited EET was performed in 13
AF patients and in 23 non-AF patients. In this sub-
group of asymptomatic subjects, ischemic ST-segment
depression was observed in 8 (62%) AF patients and in
5 (22%) non-AF patients (P = 0.030).
Stress-rest MPI was performed in 49 (56%) AF
patients and in 74 (61%) non-AF patients. Symptom-
limited bicycle exercise was performed in 21 AF
Table 1 Baseline
characteristics of the study
population
Data are expressed as
mean ± SD and n (%)
AF patients
(n = 87)
Non-AF patients
(n = 122)
P value
Age (years) 61 ± 10 59 ± 11 0.25
Male gender 62 (71%) 80 (66%) 0.39
Diabetes 13 (15%) 30 (25%) 0.089
Hypertension 56 (64%) 79 (65%) 0.95
Hypercholesterolemia 44 (51%) 53 (43%) 0.31
Family history of coronary artery disease 30 (35%) 50 (41%) 0.34
Current or previous smoking 23 (26%) 39 (32%) 0.39
C3 Coronary risk factors 26 (30%) 40 (33%) 0.66
Body mass index (kg/m2) 26.4 ± 3.6 26.4 ± 3.7 0.97
Symptoms
Asymptomatic 45 (52%) 68 (56%) 0.84
Atypical angina 24 (28%) 30 (25%)
Typical angina 18 (21%) 24 (20%)
Pre-test likelihood of coronary artery disease
Low 46 (53%) 69 (57%) 0.63
Intermediate 23 (26%) 34 (28%)
High 18 (21%) 19 (16%)
Medical therapy
Digoxin 8 (9%) 0 (0%) 0.001
Beta-blockers 28 (32%) 32 (26%) 0.35
Nitrates 13 (15%) 13 (11%) 0.36
Non-dihydropyridinic calcium antagonists 9 (10%) 5 (4%) 0.075
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patients and in 11 non-AF patients; in all these
patients, C85% of maximum age-predicted heart rate
was achieved if no stress-induced symptoms or
changes in electrocardiogram or blood pressure
occurred. Pharmacologic stress using adenosine or
dobutamine was applied in 28 AF patients and in 63
non-AF patients.
Thirty (61%) AF patients had normal perfusion at
both stress and rest. In the remaining 19 (39%) AF
patients, reversible and fixed defects were observed
in 17 and 2 patients, respectively. None of the AF
patients showed both reversible and fixed defects
(Table 3). The prevalence of abnormal MPI scans
among non-AF patients was similar. Normal myo-
cardial perfusion was observed in 50 (68%) non-AF
patients. In the remaining 24 (32%) non-AF patients,
reversible, fixed and both reversible and fixed defects
were observed in 17, 5 and 2 patients, respectively
(see Table 3). When considering only the symptom-
atic patients, stress-rest MPI was performed in 29
Table 2 MSCT coronary
angiography results in the
study population
Data are expressed as
mean ± SD and n (%)
AF patients
(n = 87)
Non-AF patients
(n = 122)
P value
Type of MSCT scanner
16-slice 18 (21%) 21 (17%) 0.53
64-slice 69 (79%) 101 (83%)
Mean heart rate during the scan (beats/min) 64 ± 7 66 ± 10 0.13
Prevalence of CAD
Normal coronary arteries 15 (17%) 41 (34%) 0.013
Non-obstructive CAD 37 (43%) 50 (41%)
Obstructive CAD 35 (40%) 31 (25%)
Obstructive single-vessel disease 19 (22%) 13 (11%) 0.027
Multi-vessel disease 16 (18%) 18 (15%) 0.48
LM and/or proximal LAD 22 (25%) 12 (10%) 0.003
High-risk features 24 (28%) 21 (17%) 0.072
Table 3 Stress testing
results in the study
population
Data are expressed as
mean ± SD and n (%)
AF patients
(n = 87)
Non-AF patients
(n = 122)
P value
Type of stress test
Exercise ECG test 38 (44%) 48 (39%) 0.53
Myocardial perfusion imaging 49 (56%) 74 (61%)
Exercise ECG test
Mean peak double product 28996 ± 7346 28854 ± 6678 0.93
Mean peak workload (Watt) 191 ± 52 186 ± 41 0.60
Ischemic ST-segment depression 15 (39%) 14 (29%) 0.32
Myocardial perfusion imaging
Myocardial perfusion findings 0.47
Normal perfusion 30 (61%) 50 (68%)
Reversible perfusion defect 17 (35%) 17 (23%)
Fixed perfusion defect 2 (4%) 5 (7%)
Reversible and fixed perfusion defects – 2 (2%)
Overall
Negative test 53 (61%) 84 (69%) 0.23
Positive test 34 (39%) 38 (31%)
Int J Cardiovasc Imaging (2011) 27:777–785 781
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symptomatic AF patients and in 31 symptomatic non-
AF patients. The prevalence of abnormal MPI scans
between these two groups of patients was similar
(8, 28% vs. 11, 36%; P = 0.58).
Overall, considering the combined EET and stress-
rest MPI results, no statistically significant difference
in the prevalence of abnormal stress tests was
observed between AF and non-AF patients (39% vs.
31%, P = 0.23; Table 3). Similarly, no statistically
significant difference in the prevalence of abnormal
stress tests was observed between symptomatic AF
and non-AF patients (38% vs. 30%, P = 0.38).
Relationship between obstructive coronary artery
disease and abnormal stress testing
Figure 1 illustrates the relationship between observa-
tions on MSCT coronary angiography and stress test
results among AF and non-AF patients. The majority
of AF and non-AF patients with normal coronary
arteries had a normal stress test (87% vs. 88%;
P = 0.90). In patients with (any) CAD, 32 (44%) AF
patients and 33 (41%) non-AF patients had an
abnormal stress test (P = 0.64).
Figure 2 illustrates the relationship between non-
obstructive and obstructive CAD identified by MSCT
coronary angiography and stress test results among
AF and non-AF patients. The majority of AF and
non-AF patients with non-obstructive CAD had a
normal stress test (59% vs. 64%; P = 0.66). In
patients with obstructive CAD, 17 (49%) AF patients
and 15 (48%) non-AF patients had an abnormal stress
test (P = 0.98).
Discussion
The results of the present study show that AF patients
have a higher prevalence of CAD, and in particular of
obstructive CAD, as compared to non-AF patients.
However, no difference in the prevalence of abnor-
mal stress testing and of functionally relevant coro-
nary lesions was observed between the two groups.
Fig. 1 Pie charts illustrating the relationship between normal
coronary arteries (panel a) and any coronary artery disease
(CAD) (panel b) identified by MSCT coronary angiography
and stress test results among atrial fibrillation (AF) and non-AF
patients. White: negative stress test. Black: positive stress test
Fig. 2 Pie charts illustrating the relationship between non-
obstructive coronary artery disease (CAD) (panel a) and
obstructive CAD (panel b) identified by MSCT coronary
angiography and stress test results among atrial fibrillation
(AF) and non-AF patients. White: negative stress test. Black:
positive stress test
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Clinical relevance of CAD in AF patients
Previous studies have shown that AF patients have a
low risk of CAD events at the time of first AF
[17, 18], but a higher long-term risk, as compared to
patients without AF [3, 6]. Aronow et al. [3], for
instance, in a prospective study of 1359 patients,
demonstrated that AF patients have a 2.2 times
increased probability of developing CAD events
during a follow-up of 42 ± 26 months, as compared
to non-AF patients. A more recent community-based
longitudinal cohort study of 2768 patients showed
that AF patients without known CAD represent a
high-risk group with increased risk for subsequent
new coronary ischemic events and mortality during a
follow-up of 6.0 ± 5.2 years [6].
These observations raise the question whether
routine evaluation of underlying CAD in AF patients
should be recommended [19]. Thus far, only few
studies addressed this issue. Abidov et al. [20], for
instance, assessed the prevalence of CAD in 384 AF
patients using stress-rest MPI; a higher prevalence of
abnormal MPI studies was observed in AF patients
as compared to patients without AF. However, in
that study, a non-negligible proportion of enrolled
patients had symptoms and/or known CAD, and the
observed difference in MPI studies results was mainly
related to a higher amount of fixed defects in the AF
group. Conversely, Askew et al. [19] showed a similar
prevalence of abnormal stress-rest MPI studies in 374
asymptomatic AF patients with no history of CAD, as
compared to 374 age- and gender-matched controls
without AF. More recently, the prevalence of CAD in
150 AF patients was assessed using MSCT coronary
angiography; a significantly higher prevalence of
CAD and obstructive CAD was observed among AF
patients, as compared to 148 patients with similar age,
gender, and pre-test likelihood of obstructive CAD. In
addition, AF was independently related to the pres-
ence of CAD and obstructive CAD, strengthening the
hypothesis that AF could be a marker of advanced
coronary atherosclerosis [8].
Atherosclerosis versus abnormal stress testing
in AF patients
Stress testing and MSCT coronary angiography pro-
vide different, complementary information about CAD
(i.e. evidence of myocardial ischemia and evidence of
coronary atherosclerosis, respectively) [9, 10]. How-
ever, how these data relate each other in AF patients is
still unknown. In the present study, the relation
between evidence of coronary atherosclerosis,
assessed by means of MSCT coronary angiography,
and the presence of abnormal stress testing was
assessed among 87 patients with paroxysmal or
persistent AF. Findings were compared to 122 patients
without a history of AF. In line with the study of Askew
et al. [19], a similar prevalence of abnormal stress tests
was observed between AF and non-AF patients (39%
vs. 31%). In addition, and importantly, no difference in
the prevalence of functionally-relevant obstructive
coronary lesions was observed between the two groups
of patients (49% vs. 48%). These data suggest that the
higher atherosclerotic burden associated to the pres-
ence of AF is not associated with a higher burden of
myocardial ischemia.
Clinical implications
The results of the present and of previous studies
suggest that a history of AF, per se, should not
represent an indication to stress testing as indiscrim-
inate first-line approach to rule out the presence of
CAD [19]. AF patients have indeed a similar preva-
lence of functionally-relevant coronary lesions as
compared to non-AF patients. Nevertheless, a higher
burden of subclinical coronary atherosclerosis is
observed in patients with AF and this higher preva-
lence may potentially explain the previously observed
higher long-term risk of CAD event in this group [3, 6].
Accordingly, more aggressive medical therapy and
risk factor modification may be justified in AF patients.
Further follow-up studies, with follow-up data, are
however needed in order to confirm this hypothesis.
Study limitations
This study has several limitations that should be
acknowledged. First, it is a case–control study, the
limitations of which are well known. Moreover, the
patient population is relatively small, including both
symptomatic and asymptomatic subjects, and no
prognostic data are available; a larger study, with
follow-up data, may provide more conclusive infor-
mation. Second, only patients with paroxysmal or
persistent AF were enrolled, while patients with
permanent AF were not included. Sixty-four-slice
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MSCT suffers indeed from limited diagnostic accuracy
in case of irregular heart rate. More recent generations
of dual source MSCT or 320-row scanners could
potentially allow imaging of the coronary arteries also
in patients with permanent AF [21]. Third, MSCT
scanners from different generations as well as manu-
facturers were used and the stress testing protocol was
not standardized, including either symptom-limited
EET or stress-rest MPI; this, however, reflects the daily
clinical practice, and allows wider applicability to the
present observations. In addition, no off-site reading of
MSCT coronary angiography and stress testing was
performed, possibly influencing inter-observer
variability.
Conclusions
AF patients have a higher prevalence of CAD, and in
particular of obstructive CAD, as compared to non-
AF patients. However, the higher burden of CAD
observed in AF patients is not associated with a
higher burden of myocardial ischemia, as compared
to non-AF patients.
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